| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Corbus Pharmaceuticals Holdings, Inc. (CRBP) has 11 insiders with recent SEC Form 4 filings, including 6 buys and 10 sells. CRBP is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| ? | 2.34M | $25.49M | - | |
| CEO | 188.2K | $2.05M | - | |
| Other | 99.2K | $1.08M | - | |
| CFO | 84.2K | $915.8K | - | |
| COO | 54.3K | $590.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 11, 2025 | Cormorant Asset Management, LP50 | - | Sell | 30,029 | $11.46 | $344,012.22 | -1.3% | +7.7% | - | |
| Oct 27, 2025 | Cohen Yuval65 | Chief Executive Officer | Sale+OE | 27,633 | $17.05 | $471,203.82 | -9.1% | -45.1% | - | |
| Oct 24, 2025 | Moran Sean F.61 | Chief Financial Officer | Sale+OE | 12,981 | $17.02 | $220,936.62 | -15.0% | -47.5% | - | |
| Oct 20, 2025 | Altmeyer Anne | Director | Sale+OE | 1,060 | $20.50 | $21,730.00 | -14.6% | -53.0% | - | |
| May 30, 2025 | Jenkins John Kenneth | Director | Sell | 2,783 | $7.35 | $20,465.35 | -98.8% | +33.4% | - | |
| May 30, 2025 | Altmeyer Anne | Director | Sell | 1,392 | $7.25 | $10,095.62 | -50.0% | +33.4% | - | |
| Mar 6, 2025 | Smethurst Dominic | Chief Medical Officer | Sell | 6,393 | $6.78 | $43,329.84 | -8.3% | +21.5% | +15.1% | |
| Feb 14, 2025 | Moran Sean F.61 | Chief Financial Officer | Sell | 2,792 | $8.76 | $24,446.47 | -3.7% | -15.3% | -11.2% | |
| Feb 14, 2025 | Cohen Yuval65 | Chief Executive Officer | Sell | 7,134 | $8.76 | $62,464.59 | -4.9% | -15.3% | -11.2% | |
| Sep 20, 2024 | Cormorant Asset Management, LP50 | - | Buy | 350,000 | $20.01 | $7,003,760.61 | +2.7% | -31.7% | -41.1% |